We Embody a Legacy of Incredible Discoveries, Exploring the Boundaries of Innovation and Science
At Zenovel, we integrate our extensive expertise across a wide range of domains, from Good Clinical Practice to Regulatory Affairs, to present valuable insights and thought leadership. Each blog reflects our intense dedication to innovation, offering a forum to share our perspectives, groundbreaking ideas, and industry expertise. Through our blogs, we hope to uplift, inform, and support scientific, medical, and pharmaceutical innovation.
The pharmaceutical industry is facing a convergence of innovation and regulation as it approaches 2026, with GxP services playing a
The recent update of ICH E6(R3) marks a significant evolution in clinical trial execution, transitioning from a compliance-centric approach to
In the pharmaceutical industry, particularly in India’s expanding market, the regulatory pathway is a crucial determinant that influences the transition
In the current pharmaceutical environment, the integrity of a company’s supply chain relies heavily on its weakest link, particularly concerning
In clinical research, Good Clinical Practice (GCP) sets ethical and quality standards. Non-compliance during audits poses systemic risks to patient
The pharmaceutical industry relies on innovation, but not all companies can fully develop a drug. Strategic licensing, including In-Licensing and
